Anakinra
Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist. It is a laboratory equipment product manufactured by Amgen.
Lab products found in correlation
21 protocols using Anakinra
Tumor-Stromal Interaction Assay
Fabrication of PLGA Microspheres
Isolation and Manipulation of HUVECs
Analgesic and Anti-inflammatory Pharmacology
Inhibition of TNF and IL-1 in Murine Arthritis
To block the function of IL-1 in the murine model, the IL-1 receptor antagonist Anakinra (Kineret; Amgen) was used as anti-IL-1 treatment (Sgroi et al., 2011 (link); Ali et al., 2015a (link)). Anakinra (1 mg/mouse in 0.1 ml of PBS) was s.c. administered daily, starting 2 days prior to exposing the knee joints with Lpl1(+sp), and continued until the termination date.
Phosphate-buffered saline was administered s.c. daily in the control treatment group, starting 2 days prior to exposing the knee joints with Lpl1(+sp), and continued until termination day.
Modulating Gut Microbiota in Rat Virus Model
Borrelia-Induced γδ T Cell Activation
Cytotoxicity Assay for Anticancer Drugs
Atherosclerosis Regression in Arthritic Mice
Modulation of Immune Responses by NTHi and RV1B
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!